ABBV FY 2018 Earnings Report — AbbVie Inc. Revenue & Financial Results | Market Cap Arena

AbbVie Inc.ABBV

FY 2018 Earnings

Reported February 27, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$32.8B	—	$28.2B	—	16.1%
Op. Income	$6.4B	—	$9.5B	—	-33.1%
Gross Margin	76.4%	—	75.0%	—	1.4pp
Net Margin	17.4%	—	18.8%	—	-1.5pp
EPS (Diluted)	$3.68	—	$3.30	—	11.5%
Free Cash Flow	$12.8B	—	$9.4B	—	35.6%

Revenue Flow

Item	Amount
REVENUE	$32.8B
Cost of Revenue	$7.7B
GROSS PROFIT	$25.0B
R&D Expenses	$10.8B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$7.4B
Other Expenses	$500M
Operating Expenses	$18.7B
Cost & Expenses	$26.4B
OPERATING INCOME	$6.4B
Interest Income	$204M
Interest Expense	$1.3B
Other Income/Expenses	-$1.2B
INCOME BEFORE TAX	$5.2B
Income Tax Expense	-$490M
Net Income from Continuing Ops	$5.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.7B
D&A	$1.8B
EBIT	$6.5B
EBITDA	$8.3B
EPS	$4
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$32.8B
Cost of Revenue	$7.7B
GROSS PROFIT	$25.0B
R&D Expenses	$10.8B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$7.4B
Other Expenses	$500M
Operating Expenses	$18.7B
Cost & Expenses	$26.4B
OPERATING INCOME	$6.4B
Interest Income	$204M
Interest Expense	$1.3B
Other Income/Expenses	-$1.2B
INCOME BEFORE TAX	$5.2B
Income Tax Expense	-$490M
Net Income from Continuing Ops	$5.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.7B
D&A	$1.8B
EBIT	$6.5B
EBITDA	$8.3B
EPS	$4
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$5.7B
Depreciation & Amortization	$1.8B
Stock-Based Compensation	$421M
Deferred Income Tax	$424M
Other Non-Cash Items	$6.3B
Change in Working Capital	-$1.1B
OPERATING CASH FLOW	$13.4B
Capital Expenditure	-$638M
Acquisitions (Net)	-$736M
Purchases of Investments	-$1.8B
Sales/Maturities of Investments	$2.2B
Other Investing Activities	$0
NET CASH FROM INVESTING	-$1.0B
Net Debt Issuance	$3.2B
Common Stock Repurchased	-$12.0B
Common Dividends Paid	-$5.6B
Other Financing Activities	-$31M
NET CASH FROM FINANCING	-$14.4B
FREE CASH FLOW	$12.8B
Net Change in Cash	-$2.0B

Balance Sheet

Item	Amount
Cash & Equivalents	$7.3B
Short-Term Investments	$772M
Net Receivables	$5.4B
Inventory	$1.6B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$16.9B
PP&E (Net)	$2.9B
Goodwill	$15.7B
Intangible Assets	$21.2B
Long-Term Investments	$1.4B
Tax Assets	$0
Other Non-Current Assets	$1.2B
TOTAL NON-CURRENT ASSETS	$42.4B
TOTAL ASSETS	$59.4B
Account Payables	$1.5B
Short-Term Debt	$5.3B
Deferred Revenue	$0
Other Current Liabilities	$1.6B
TOTAL CURRENT LIABILITIES	$17.2B
Long-Term Debt	$35.0B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$3.8B
Other Non-Current Liabilities	$11.8B
TOTAL NON-CURRENT LIABILITIES	$50.6B
TOTAL LIABILITIES	$67.8B
Common Stock	$18M
Additional Paid-In Capital	$14.8B
Retained Earnings	$3.4B
Treasury Stock	-$24.1B
Accum. Other Comp. Income	-$2.5B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	-$8.4B
Minority Interest	$0
TOTAL EQUITY	-$8.4B
TOTAL LIABILITIES & EQUITY	$59.4B
Total Debt	$40.3B
Net Debt	$33.0B